Bobbie Farsides

Bobbie Farsides

Auto-generated profile, based on publicly available information

Bobbie Farsides

Brighton and Sussex Medical School, Brighton, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Sociology of Health & Illness
Verified
Journal Article
Open access
PDF file
SWSteven P. Wainwright
Steven P. Wainwright
CWClare Williams
Clare Williams
MMMike Michael
Mike Michael
BFBobbie Farsides
Bobbie Farsides
ACAlan Cribb
Alan Cribb
Most accounts of the ethics of stem cell research are de‐ contextualised reviews of the ethical and legal literature. In this chapter we present a socially embedded account of some of the ethical implications of stem cell research, from the perspectives of scientists directly involved in this area. Based on an ethnography of two leading embryonic stem cell laboratories in the UK, our data form part of the findings from a larger project mapping the scientific, medical, social and ethical dimensions of innovative stem cell treatment, focusing on the areas of liver cell and pancreatic islet cell transplantation. We explore three key issues: what individual scientists themselves view as ethical sources of human embryos and stem cells; their perceptions of human embryos and stem cells; and how scientists perceive regulatory frameworks in stem cell research. We argue that these dimensions of laboratory practice are all examples of ‘ethical boundary‐work’, which is becoming an integral part of the routine practice and performance of biomedical science. Our work adds to the relatively few sociological studies that explore ethics in clinical settings and to an even smaller body of work that explores scientists’ views on the ethical issues relating to their research.

1 February 2002 in Social Science & Medicine
Verified
Journal Article
Closed access
CWClare Williams
Clare Williams
PAPriscilla Alderson
Priscilla Alderson
BFBobbie Farsides
Bobbie Farsides

22 August 2009 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
FAFasil Tekola Ayele
Fasil Tekola Ayele
SBSusan Bull
Susan Bull
BFBobbie Farsides
Bobbie Farsides
MNMelanie Newport
Melanie Newport
AAAdebowale Adeyemo
Adebowale Adeyemo
GDGail Davey
Gail Davey
The consent process for a genetic study is challenging when the research is conducted in a group stigmatized because of beliefs that the disease is familial. Podoconiosis, also known as 'mossy foot', is an example of such a disease. It is a condition resulting in swelling of the lower legs among people exposed to red clay soil. It is a very stigmatizing problem in endemic areas of Ethiopia because of the widely held opinion that the disease runs in families and is untreatable. The aim of this study was to explore the impact of social stigma on the process of obtaining consent for a study on the genetics of podoconiosis in Southern Ethiopia.

21 July 2009 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
FAFasil Tekola Ayele
Fasil Tekola Ayele
SBSusan J. Bull
Susan J. Bull
BFBobbie Farsides
Bobbie Farsides
MNMelanie Newport
Melanie Newport
AAAdebowale Adeyemo
Adebowale Adeyemo
GDGail Davey
Gail Davey
Currently there is increasing recognition of the need for research in developing countries where disease burden is high. Understanding the role of local factors is important for undertaking ethical research in developing countries. We explored factors relating to information and communication during the process of informed consent, and the approach that should be followed for gaining consent. The study was conducted prior to a family-based genetic study among people with podoconiosis (non-filarial elephantiasis) in southern Ethiopia. We adapted a method of rapid assessment validated in The Gambia. The methodology was entirely qualitative, involving focus-group discussions and in-depth interviews. Discussions were conducted with podoconiosis patients and non-patients in the community, fieldworkers, researchers, staff of the local non-governmental organisation (NGO) working on prevention and treatment of podoconiosis, and community leaders. We found that the extent of use of everyday language, the degree to which expectations of potential participants were addressed, and the techniques of presentation of information had considerable impact on comprehension of information provided about research. Approaching podoconiosis patients via locally trusted individuals and preceding individual consent with community sensitization were considered the optimal means of communication. Prevailing poverty among podoconiosis patients, the absence of alternative treatment facilities, and participants' trust in the local NGO were identified as potential barriers for obtaining genuine informed consent. Researchers should evaluate the effectiveness of consent processes in providing appropriate information in a comprehensible manner and in supporting voluntary decision-making on a study-by-study basis. Informed consent to biomedical research in developing countries is a highly topical issue. When consent forms and processes are simply borrowed from developed countries, obtaining genuine informed consent becomes extremely challenging. This paper examines how a quick and relatively simple intervention (Rapid Assessment) can influence the design and implementation of informed consent processes in the context of biomedical research involving poor, socially stigmatized and illiterate communities in a developing country. The paper goes on to discuss the effect of social, cultural, and economic factors identified by the intervention in a particular context and demonstrates how knowledge of these influences helped to develop a socially relevant and practical consent process prior to conducting a programme of community-based genetic research. The paper concludes that this intervention is an effective and economical means by which to ensure the efficacy and ethical integrity of consent processes when recruiting participants to new research sites, even within countries with which researchers are already acquainted.

1 October 2006 in Social Science & Medicine
Verified
Journal Article
Closed access
SWSteven P. Wainwright
Steven P. Wainwright
CWClare Williams
Clare Williams
MMMike Michael
Mike Michael
BFBobbie Farsides
Bobbie Farsides
ACAlan Cribb
Alan Cribb

8 August 2017 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
GSGabrielle Natalie Samuel
Gabrielle Natalie Samuel
SDSandi Dheensa
Sandi Dheensa
BFBobbie Farsides
Bobbie Farsides
AFAngela Fenwick
Angela Fenwick
ALAnneke Lucassen
Anneke Lucassen
This paper proposes a refocusing of consent for clinical genetic testing, moving away from an emphasis on autonomy and information provision, towards an emphasis on the virtues of healthcare professionals seeking consent, and the relationships they construct with their patients. We draw on focus groups with UK healthcare professionals working in the field of clinical genetics, as well as in-depth interviews with patients who have sought genetic testing in the UK’s National Health Service (data collected 2013–2015). We explore two aspects of consent: first, how healthcare professionals consider the act of ‘consenting’ patients; and second how these professional accounts, along with the accounts of patients, deepen our understanding of the consent process. Our findings suggest that while healthcare professionals working in genetic medicine put much effort into ensuring patients’ understanding about their impending genetic test, they acknowledge, and we show, that patients can still leave genetic consultations relatively uninformed. Moreover, we show how placing emphasis on the informational aspect of genetic testing is not always reflective of, or valuable to, patients’ decision-making. Rather, decision-making is socially contextualised – also based on factors outside of information provision. A more collaborative on-going consent process, grounded in virtue ethics and values of honesty, openness and trustworthiness, is proposed.